Scandinavian Medical Solutions A/S
SMSMED.CO · CPH
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.62 | 4.95 | 1.03 |
| FCF Yield | 0.00% | -8.32% | -17.49% | -20.24% |
| EV / EBITDA | 5.59 | 9.97 | 14.22 | 5.94 |
| Quality | ||||
| ROIC | 0.15% | 8.67% | 12.49% | 17.29% |
| Gross Margin | 13.97% | 17.70% | 18.16% | 20.52% |
| Cash Conversion Ratio | -7.50 | 0.25 | -0.50 | -0.72 |
| Growth | ||||
| Revenue 3-Year CAGR | 8.68% | 27.05% | 38.71% | 38.12% |
| Free Cash Flow Growth | -126.97% | 69.35% | -102.16% | -704.56% |
| Safety | ||||
| Net Debt / EBITDA | 5.59 | 1.34 | 0.97 | -1.78 |
| Interest Coverage | 0.83 | 2.63 | 17.02 | 58.07 |
| Efficiency | ||||
| Inventory Turnover | 1.98 | 2.21 | 1.82 | 1.70 |
| Cash Conversion Cycle | 138.19 | 127.22 | 150.45 | 137.31 |